Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Laboratorios Rovi
- Roche
Comparative performance (base 100)
Each asset is worth 100 at October 20, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Bonds and private debt have no comparable price series: they appear only in the table.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | Laboratorios RoviStock | RocheStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | −3.2% | Unavailable |
| Annualized performanceAverage annual return that would produce the same total performance. | −3.3% | Unavailable |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 28.0% | Unavailable |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −37.3% | Unavailable |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | -0.15 | Unavailable |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −2.2% | Unavailable |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 2.98B € | Unavailable |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 16.1 | Unavailable |
| Price-to-SalesMarket capitalization divided by annual revenue. | 3.9 | Unavailable |
| Net marginShare of revenue retained as profit. | 24.0% | Unavailable |
| Return on equityReturn on equity (ROE). | 28.7% | Unavailable |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +20.0% | Unavailable |
| Dividend yieldAnnual dividend relative to the share price. | 1.65% | Unavailable |
| Debt / equityFinancial debt relative to shareholders' equity. | 15% | Unavailable |
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.